BenjiFuji
2022-08-10

$Novavax(NVAX)$Bearish on Novovax as they cut their revenue expectations by half. 50% is no small matter.

Aside, clinically, Pfizer and Moderna are muchfaster ahead with their omicron vaccines and Novovax has yet to prove itself to be better than mRNA technology.

On the numbers front, the valuation looks horrible with negative ROE, EBIT per share, ROIC, operative margin trends. Based on PB, a 48 ratio sounds insane.

I am not certain about the MOAT of this company and hence will not attempt any sensible valuation.

My advise will be to STAY AWAY.

What do you think? Let me know if you have some valuable insights for Novovax.

Aside, some of you will be facing situations like this right now. Oh ya did I mention there's a new virus from China called the Henipavirus spreading now? [Facepalm] 

@TigerStars@CaptainTiger@MillionaireTiger

NVAX: What's your target price after earnings miss?
【KEY POINTS】 1. Novavax stock plunged 31% after the company provided its Q2 update. 2. The vaccine maker badly missed revenue and earnings estimates and slashed its full-year revenue guidance. 【Topic】What's your thoughts on NVAX earnings? Target price after earnings miss?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1